Immediate acid‐suppressing effects of ranitidine hydrochloride and rabeprazole sodium following initial administration and reintroduction: A randomized, cross‐over study using wireless pH monitoring capsules
- 30 March 2009
- journal article
- research article
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 24 (4), 639-645
- https://doi.org/10.1111/j.1440-1746.2008.05644.x
Abstract
Histamine 2 receptor antagonists and proton-pump inhibitors, drugs that are widely used for the treatment of acid-related diseases, have different clinical characteristics. The objective of this study was to compare the acid-suppressing effects of ranitidine hydrochloride and those of rabeprazole sodium at the first administration and re-administration after withdrawal. The study was designed as an open-label, randomized, two-way cross-over trial. Seven Helicobacter pylori-negative healthy volunteers were enrolled in this study. Ranitidine hydrochloride (300 mg/day) or rabeprazole sodium (20 mg/day) was administered from days 1 to 7 and from days 11 to 13. The percentage of time with gastric pH < 4 and the median gastric pH were evaluated for 15 consecutive days by a Bravo capsule fixed to the stomach. On day 1, there was no significant difference between the acid-suppressing effects of the two drugs (ranitidine vs rabeprazole: not significant). Although rabeprazole sodium maintained a potent and stable effect from days 2 to 7 (ranitidine vs rabeprazole: P < 0.05), the effect of ranitidine hydrochloride was attenuated after day 4. In addition, the effect of ranitidine hydrochloride at re-administration was attenuated (days 11, 12, and 13 vs pre-administration: not significant). In view of our observations, we expect symptoms associated with gastric acidity to be more adequately controlled with rabeprazole sodium in the short term when compared to ranitidine hydrochloride.Keywords
This publication has 22 references indexed in Scilit:
- A New Procedure for 16 Consecutive Days Monitoring of Intragastric pHJournal of Clinical Gastroenterology, 2008
- Four-day continuous gastric pH monitoring following anti-acid secretory drug administration: cross-over test to assess the early effectsAlimentary Pharmacology & Therapeutics, 2007
- Systematic review: maintenance treatment of gastro‐oesophageal reflux disease with proton pump inhibitors taken ‘on‐demand’Alimentary Pharmacology & Therapeutics, 2007
- The absorption of bismuth from oral doses of tripotassium dicitrato bismuthateAlimentary Pharmacology & Therapeutics, 2007
- New method for long-term monitoring of intragastric pHWorld Journal of Gastroenterology, 2007
- Comparative study of the speed of acid-suppressing effects of oral administration of cimetidine and famotidineJournal of Gastroenterology and Hepatology, 2005
- The comparative effects of single intravenous doses of omeprazole and famotidine on intragastric pHThe Esophagus, 2004
- Tolerance to famotidine and ranitidine treatment after 14 days of administration in healthy subjects without Helicobacter pylori infectionJournal of Gastroenterology and Hepatology, 2003
- Comparison of the kinetic disposition of and serum gastrin change by lansoprazole versus rabeprazole during an 8-day dosing scheme in relation to CYP2C19 polymorphismEuropean Journal of Clinical Pharmacology, 2001
- LONG-TERM EFFECTS AND AFTER-EFFECTS OF TREATMENT OF DUODENAL ULCER WITH METIAMIDEThe Lancet, 1977